Enterprise Value
$423.23 M
+$1.52 M+0.36%
4 min ago
Summary
- As of February 7, 2025, HRTX enterprise value is $423.23 million, with a rise of +$1.52 million (+0.36%) during the most recent trading day.
- Over the past year, HRTX enterprise value has dropped by -$76.38 million (-15.29%).
- HRTX enterprise value is now -86.62% below its all-time high of $3.16 billion.
Performance
HRTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
HRTX Enterprise Value Trends
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
todaytoday | +0.4% | +0.6% | +0.6% |
1 m1 month | +5.3% | +8.5% | +8.5% |
3 m3 months | +0.4% | +0.6% | +0.6% |
6 m6 months | -9.9% | -12.5% | -12.8% |
ytdytd | +9.9% | +16.4% | +16.4% |
1 y1 year | -15.3% | -22.4% | -23.3% |
5 y5 years | -78.0% | -86.3% | -91.8% |
HRTX Enterprise Value Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -2.1% | $381 M | +11.2% | |
3 m | 3-month | $496 M | -14.7% | $318 M | +33.0% |
6 m | 6-month | $539 M | -21.6% | $318 M | +33.0% |
1 y | 1-year | $751 M | -43.6% | $318 M | +33.0% |
3 y | 3-year | $1.02 B | -58.7% | $230 M | +84.2% |
5 y | 5-year | $1.96 B | -78.4% | $230 M | +84.2% |
alltime | all time | $3.16 B | -86.6% | -$12 M | +3593.9% |
Heron Therapeutics Enterprise Value History
Date | Value |
---|---|
2025 | $423.23 M(+9.9%) |
2024 | $385.16 M(-5.9%) |
2023 | $409.44 M(-6.9%) |
2022 | $440.00 M(-56.0%) |
2021 | $1.00 B(-46.0%) |
2020 | $1.85 B(-10.5%) |
2019 | $2.07 B(+3.5%) |
2018 | $2.00 B(+89.9%) |
2017 | $1.05 B(+89.8%) |
2016 | $555.05 M(-37.7%) |
2015 | $891.07 M(+299.7%) |
2014 | $222.95 M(+58.2%) |
2013 | $140.89 M(+24.4%) |
2012 | $113.21 M(+302.3%) |
2011 | $28.14 M(+76.4%) |
2010 | $15.96 M(-62.7%) |
2009 | $42.73 M(+1310.7%) |
2008 | $3.03 M(-80.0%) |
2007 | $15.14 M(-53.4%) |
Date | Value |
---|---|
2006 | $32.52 M(-14.2%) |
2005 | $37.89 M(-0.8%) |
2004 | $38.19 M(-24.3%) |
2003 | $50.47 M(+193.7%) |
2002 | $17.18 M(-67.8%) |
2001 | $53.39 M(+28.6%) |
2000 | $41.50 M(-39.6%) |
1999 | $68.76 M(-35.4%) |
1998 | $106.46 M(-15.4%) |
1997 | $125.85 M(-11.2%) |
1996 | $141.69 M(+51.8%) |
1995 | $93.36 M(+32.1%) |
1994 | $70.67 M(-3.9%) |
1993 | $73.55 M(-33.2%) |
1992 | $110.04 M(+2.5%) |
1991 | $107.40 M(+364.3%) |
1990 | $23.13 M(-58.0%) |
1989 | $55.09 M(+16.4%) |
1988 | $47.31 M(+35.4%) |
1987 | $34.95 M |
FAQ
- What is Heron Therapeutics enterprise value?
- What is the all time high enterprise value for Heron Therapeutics?
- What is HRTX enterprise value year-to-date change?
- What is Heron Therapeutics enterprise value year-on-year change?
What is Heron Therapeutics enterprise value?
The current enterprise value of HRTX is $423.23 M
What is the all time high enterprise value for Heron Therapeutics?
Heron Therapeutics all-time high enterprise value is $3.16 B
What is HRTX enterprise value year-to-date change?
Heron Therapeutics enterprise value has changed by +$38.07 M (+9.88%) since the beginning of the year
What is Heron Therapeutics enterprise value year-on-year change?
Over the past year, HRTX enterprise value has changed by -$76.38 M (-15.29%)